Recession or no recession?

Earn While You Learn! ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ [EARN WHILE YOU LEARN! JOIN OUR FREE LIVE TRADING SESSION!]( Hello investor, Recession or no recession? Yesterday’s trading gave a preview of what may be coming for the stock market. The market soared after initial claims fell 17,000 to 233,000 in the week ended Aug. 2, according to Labor Department data. That data point was good enough for the S&P 500 to have its best day since 2022 — despite the recent sell-off on Monday. So, the market is likely to be highly volatile over the next few key economic data readings. Investors are trying to figure out if the economy is heading into a recession or not. For now, Chris Zaccarelli at Independent Advisor Alliance believes the recent pullback was an overreaction. - “Some good news with jobless claims coming in less than expected,” said Chris Zaccarelli at Independent Advisor Alliance. “It’s hard to believe a recession has already begun. We are exercising caution, but think that the panic that started earlier in the month was overblown.” Chris Zaccarelli at Independent Advisor Alliance (Photo: CNBC) Steve Sosnick at Interactive Brokers doesn’t feel that the data of initial jobless claims was enough to eliminate the possibility of a recession. Regardless, traders are still eager to buy dips. Nobody can blame them. The strategy of buying dips has been marvelously profitable in the last 14+ years. - “Can we say that today’s number has quelled the looming recession fears? Absolutely not,” said Steve Sosnick at Interactive Brokers. “Can we say that stock traders remain fixated on buying dips and chasing rallies? Absolutely yes.” Right now, the market will watch for any signs of an economic slowdown. Expedia Group warned of “softening” travel demand in July during its earnings release. The company adjusted its expectations for the rest of the year without offering specific numbers. - “…in July, we have seen a more challenging macro environment and a softening in travel demand. We are therefore adjusting our expectations for the rest of the year,” said Chief Executive Officer Ariane Gorin. Expedia spotlighted July as the troubling month for travel demand, so the next few weeks will be important to see if the slowdown spreads to other sectors in the economy. Follow London’s Billionaire Investor Into A Red-Hot Sector With This Pick And Shovel Play Have you heard of Len Blavatnik? Probably not. Despite his fantastic wealth, he keeps a low profile. He is London’s richest person, and his net worth of $35.4 billion would place him in the top 20 wealthiest people in the world. - He is an “anomaly” among billionaires because of his constant reinvention in different sectors. He dominated aluminum in Russia. Then oil, then plastics. The entertainment industry was next. - “He is an anomaly. A lot of families make money in a certain sector and their focus will stay there. Yes, they’ll do stuff outside to diversify but never to the same extent as Len. He is kind of like Madonna was in her career. A different person with every album,” said Samy Dwek, chief executive officer of the Family Office Doctor. Len Blavatnik (Photo: Paddock Magazine) He made his fortune by having the talent to spot the next trend. So, investors should pay attention to where he moves in. What’s the next stage? He sees biotech as the hottest sector to be in. He already invested hundreds of millions of dollars into the industry. And today, you will have the same opportunity to invest in this red-hot sector. Today’s Pick: Bio-Techne Corp. (TECH) Wild West: Surely, biotech is an exciting industry to be in. But it’s like the Wild West. Every “potential breakthrough” isn’t guaranteed to succeed in the testing phase -- let alone getting approved by the FDA. What’s more, one failed test or one rejection by the FDA can hammer a stock’s price. Far safer pick: With today’s pick, you will have the best “pick and shovel” play on biotech. It offers materials required to conduct tests to pharma companies. What does it mean? The company makes money every time a client conducts experiments that require BioTechne’s materials. - For example, mRNA may be the greatest medical breakthrough since Penicillin. It is the main technology behind covid vaccines. Biotechne offers a critical **protein that makes mRNA possible. That business is lucrative. Investors are overlooking this company because the current management delivered strong revenue growth since FY14: (Source: Bio-Techne) Consumable product: Because most of its materials are consumed during experiments, the company gets repeated orders. As a result, its growth has been predictable.  (Source: Bio-Techne) Bio-Techne operates in several markets that are growing mostly by double-digit annually. And they haven’t penetrated more than 10% of these markets. The growth potential is plenty.  (Source: Bio-Techne) Bottom line: Bio-Techne looks like a low-risk play to bet on the future of biotechnology. Most of its products are consumable which delivers more reliable revenue streams. So, this is a safe biotech stock to own right now. [EARN WHILE YOU LEARN! JOIN OUR FREE LIVE TRADING SESSION!](       © All Rights Reserved, Trade Alliance [Unsubscribe]( | [Manage Preferences](